The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication.

Source:http://linkedlifedata.com/resource/pubmed/id/19289855

Blood 2009 May 21 113 21 5090-3

Download in:

View as

General Info

PMID
19289855